Buffered Lidocaine in the Pediatric Dental Patient
Launched by GEISINGER CLINIC · Aug 12, 2019
Trial Information
Current as of July 09, 2025
Completed
Keywords
ClinConnect Summary
This project's primary aim is to evaluate pain perception in buffered vs non-buffered local anesthesia in children undergoing routine dental treatment. The secondary aim is to evaluate if the buffered solution results in a faster onset of local anesthesia compared to conventional solution. Through a well-designed study, we hope to contribute to the profession's understanding of advanced local anesthesia techniques in children.
This study has been designed as a longitudinal, double blind, crossover study. Specifically, a split mouth design will be implemented to investigate if there is a si...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients requiring restorative or surgical dental treatment on two occasions on opposite sides of the mouth; either both maxillary or both mandibular quadrant/sextant involving comparable teeth/areas
- • 2. Patients able to undergo dental treatment in the dental clinic without general anesthesia, sedation, or anxiolysis
- • 3. Patients 4-17 years of age
- • 4. Patients classified as ASA I or ASA II
- • 5. Patients of parents who can read, write and give consent in English
- Exclusion Criteria:
- • 1. Patients with allergy to local anesthetic
- • 2. Patients who are pregnant or nursing
- • 3. Patients with cardiac concerns or contraindications to epinephrine
- • 4. Patients unable to undergo dental treatment in the clinic for behavior or medical reasons
- • 5. Patients requiring anxiolysis, sedation, or general anesthesia
- • 6. Patients unable to keep dental appointments or return for dental appointments
- • 7. Patients who do not meet inclusion criteria
- • 8. Patients who experience a missed block (IANB) during injection
About Geisinger Clinic
Geisinger Clinic is a leading healthcare organization based in Pennsylvania, recognized for its commitment to innovative patient care and research. As a clinical trial sponsor, Geisinger Clinic integrates cutting-edge medical research with a focus on improving health outcomes through evidence-based practices. The organization leverages its extensive electronic health record system and diverse patient population to facilitate comprehensive clinical studies that advance medical knowledge and enhance therapeutic options. With a strong emphasis on collaboration and community engagement, Geisinger Clinic aims to translate research findings into practical solutions that benefit patients and the healthcare system as a whole.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Danville, Pennsylvania, United States
Patients applied
Trial Officials
Gayatri Malik, DMD, PhD
Principal Investigator
Geisinger Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials